Rabeprazole ( DrugBank: Rabeprazole )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	2
51	全身性強皮症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03237741 (ClinicalTrials.gov)	August 7, 2017	31/7/2017	Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of ...	A Phase I Open-Label Study to Determine the Relative Bioavailability of GDC-0134 and to Investigate ...	Amyotrophic Lateral Sclerosis	Drug: Reference capsule GDC-0134;Drug: Prototype capsule GDC-0134;Drug: rabeprazole	Genentech, Inc.	Quotient Clinical	Completed	30 Years	65 Years	Female	24	Phase 1	United Kingdom
2	NCT02655614 (ClinicalTrials.gov)	May 31, 2016	7/1/2016	A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Par ...	A Phase I, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Single- and Multiple-Ascending ...	Amyotrophic Lateral Sclerosis	Drug: GDC-0134;Drug: Placebo;Drug: Rabeprazole;Drug: Midazolam;Drug: Caffeine	Genentech, Inc.	NULL	Completed	18 Years	N/A	All	54	Phase 1	United States;Canada;Netherlands

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000020701	2005/03/10	22/01/2016	The efficacy and safety of rabeprazolesodium 20mg against reflux esophagitis associated with systemi ...	The efficacy and safety of rabeprazolesodium 20mg against reflux esophagitis associated with systemi ...	reflux esophagitis associated with systemic scleroderma	Rabeprazolesodium 1 tablet a day will be added to subjects whose symptom does not improve with 1 tab ...	Faculty of Medicine,Institute of Medical, Pharmaceutical and Health Sciences,Kanazawa University	NULL	Complete: follow-up complete	Not applicable	Not applicable	Male and Female	40	Not applicable	Japan